Back

Role of surgery for aortic valve treatment in the era of TAVR

30 August 2024 (08:37 - 08:47)
Organised by: Logo
Congress Presentation Part of: Innovations and future frontiers in aortic, mitral, and tricuspid valve therapies Valvular Heart Disease ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Sabine Bleiziffer

Heart Centre Central Clinic Bad Berka, Bad Berka (Germany)

10 More presentations in this session

Presentation thumbnail
Introduction
Video
Presentation thumbnail
Considerations for lifetime management of aortic stenosis
Doctor A. Gupta (Los Angeles, US)
Slides Video
Presentation thumbnail
The future of aortic valve intervention: asymptomatic aortic stenosis, moderate aortic stenosis, bicuspid aortic stenosis, aortic insufficiency
Professor H. Eltchaninoff (Rouen, FR)
Slides Video
Presentation thumbnail
Innovations and future frontiers in aortic, mitral, and tricuspid valve therapies - panel discussion 1
Video
Presentation thumbnail
Transcatheter mitral valve therapies: overcoming hurdles, seizing opportunities
Doctor R. Makkar (Los Angeles, US)
Slides Video

Access the full session

Session thumbnail
Innovations and future frontiers in aortic, mitral, and tricuspid valve therapies
Video

The Event

Event poster

ESC Congress 2024

30 August 2024 08:37 CET
You may be interested in
thumbnail
Congress Presentation
Treatment of aortic stenosis and trial evidence: diminishing role for surgery in routine clinical practice? - pro
thumbnail
Congress Session
Innovations and future frontiers in aortic, mitral, and tricuspid valve therapies
thumbnail
Congress Session
Great Debates: therapeutic controversies of aortic stenosis in 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources